# Apomorphine in Parkinson's Disease Patients With Visual Hallucinations

> **NCT02702076** · PHASE2 · UNKNOWN · sponsor: **University Medical Center Groningen** · enrollment: 35 (estimated)

## Conditions studied

- Parkinson's Disease
- Hallucinations, Visual

## Interventions

- **DRUG:** Apomorphine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02702076
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-05
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2017-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02702076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02702076, "Apomorphine in Parkinson's Disease Patients With Visual Hallucinations". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT02702076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*